Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hasselblatt

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
Neuropathology and Applied Neurobiology|February 13, 2022
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYCMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Cancer Medicine|May 27, 2016
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007Kerstin Bartelheim, Karolina Nemes, Angela Seeringer, et al.
Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.
Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.
The American Journal of Surgical Pathology|April 21, 2022
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni SyndromeMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Acta Neuropathologica|December 17, 2013
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entityAndrey Korshunov, Dominik Sturm, Marina Ryzhova, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
Cell Death & Disease|September 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumorsLena Blümel, Nan Qin, Johannes Berlandi, et al.
Acta Neuropathologica|November 17, 2019
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adultsChristian Thomas, Annika Wefers, Susanne Bens, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Neuropathology and Applied Neurobiology|February 13, 2022
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYCMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Cancer Medicine|May 27, 2016
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007Kerstin Bartelheim, Karolina Nemes, Angela Seeringer, et al.
Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.
Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.
The American Journal of Surgical Pathology|April 21, 2022
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni SyndromeMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Acta Neuropathologica|December 17, 2013
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entityAndrey Korshunov, Dominik Sturm, Marina Ryzhova, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
Cell Death & Disease|September 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumorsLena Blümel, Nan Qin, Johannes Berlandi, et al.
Acta Neuropathologica|November 17, 2019
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adultsChristian Thomas, Annika Wefers, Susanne Bens, et al.
Pageof 21